Washington, DC (June 30, 2016) —British A. Robinson, CEO of the Women’s Heart Alliance, issued the following statement today in response to a new study
in JAMA Cardiology showing the decline in death rates for heart disease is slowing. Ms. Robinson highlights what the new study means for women in particular:“Though there have been significant medical advances in the last several decades to help prevent heart disease, it remains the number one killer of women in the United States. This latest study underscores the need to join forces across all sectors and double down on efforts to ensure women have the tools and support they need to prevent heart disease and stop this killer in its tracks. Heart disease is under-researched, under-funded and under-diagnosed in women, which is why we formed the Women’s Heart Alliance – to reduce gender disparities, improve health equity and encourage prevention, especially among young women and those most at risk.”
About the Women’s Heart Alliance
The Women’s Heart Alliance (WHA) was formed to raise awareness, encourage action and drive new research to fight women’s heart disease. It’s a unique collaboration between two of America’s leading medical institutions—the Barbra Streisand Women’s Heart Center at Cedars-Sinai Heart Institute and the Ronald O. Perelman Heart Institute at New York-Presbyterian Hospital/Weill Cornell Medical Center—and two major philanthropists and leaders in business and entertainment, Barbra Streisand and Ronald O. Perelman. Learn more at www.fighttheladykiller.org, and on Facebook, Twitter @FightLadyKiller and Instagram @fighttheladykiller.